Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

NCT02652975 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT02652975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02652975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2015
Completion date
June 30, 2018
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, cardiovascular disease, endothelial dysfunction, metabolic syndrome